Keyu Li Selected Research

Keyu Li Research Topics

Disease

16	Neoplasms (Cancer) 02/2024 - 08/2010
8	Adenocarcinoma 02/2024 - 01/2020
4	Neoplasm Metastasis (Metastasis) 02/2024 - 11/2016
4	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 01/2020
2	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 03/2017
2	Cholangiocarcinoma 01/2022 - 11/2016
2	Inflammation (Inflammations) 10/2019 - 04/2014
2	Liver Neoplasms (Liver Cancer) 03/2017 - 02/2016
2	Carcinogenesis 01/2017 - 11/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 02/2016
2	Osteoarthritis 04/2016 - 04/2014
1	Foreign Bodies (Foreign Body) 01/2024
1	Thrombosis (Thrombus) 01/2024
1	Liver Diseases (Liver Disease) 11/2023
1	COVID-19 01/2023
1	Neuroendocrine Carcinoma 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2019
1	Lung Injury 10/2019
1	Acute Lung Injury 10/2019
1	Obesity 04/2016
1	Vascular Diseases (Vascular Disease) 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2014

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 02/2024 - 11/2016
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	Chimeric Antigen ReceptorsIBA 11/2023 - 03/2017
2	AntibodiesIBA 01/2023 - 01/2023
2	NivolumabIBA 01/2023 - 11/2022
2	Focal Adhesion Protein-Tyrosine KinasesIBA 11/2022 - 01/2021
2	ResveratrolIBA 04/2016 - 04/2014
1	Metalloproteases (Metalloproteinases)IBA 02/2024
1	Biomarkers (Surrogate Marker)IBA 02/2024
1	DisintegrinsIBA 02/2024
1	AntigensIBA 11/2023
1	GlycogenIBA 11/2023
1	Semaphorins (Semaphorin)IBA 10/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2023
1	plexinIBA 10/2023
1	Tyrosine Kinase InhibitorsIBA 09/2023
1	ErbB Receptors (EGF Receptor)IBA 09/2023
1	GVAX vaccineIBA 01/2023
1	urelumabIBA 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	PEGPH20IBA 11/2022
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 11/2022
1	Hyaluronic Acid (Hyaluronan)IBA 11/2022
1	Programmed Cell Death 1 ReceptorIBA 11/2022
1	Indicators and Reagents (Reagents)IBA 10/2022
1	Granzymes (Granzyme)IBA 01/2022
1	CytokinesIBA 01/2022
1	Nuclear RNAIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 10/2019
1	Peroxidase (Myeloperoxidase)IBA 10/2019
1	Double-Stranded RNA (RNA, Double Stranded)IBA 10/2019
1	LipopolysaccharidesIBA 10/2019
1	HMGB1 Protein (HMG1)IBA 10/2019
1	Messenger RNA (mRNA)IBA 01/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017
1	CateninsIBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 11/2016
1	MicroRNAs (MicroRNA)IBA 11/2016
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2016
1	Leukemia Inhibitory FactorIBA 11/2016
1	Estrogen ReceptorsIBA 01/2016
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2016
1	Immunoglobulin FragmentsIBA 11/2014
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2014
1	Small Interfering RNA (siRNA)IBA 04/2014
1	ProteomeIBA 08/2010

Therapy/Procedure

7	Therapeutics 11/2023 - 03/2017
5	Immunotherapy 01/2023 - 03/2017
3	Radiotherapy 02/2024 - 01/2020
3	Neoadjuvant Therapy 11/2022 - 01/2020
1	Radioimmunotherapy 02/2024
1	Bronchoscopes 01/2024
1	Pancreatectomy 01/2021
1	Intra-Articular Injections 04/2016
1	Liver Transplantation 02/2016
1	Ligation 02/2016
1	Bridge Therapy 02/2016
1	Hepatectomy 02/2016